|
1
|
Whiting J, Sano T, Saka M, Fukagawa T,
Katai H and Sasako M: Follow-up of gastric cancer: A review.
Gastric Cancer. 9:74–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosell R, Carcereny E, Gervais R,
Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R,
Pallares C, Sanchez JM, et al: Erlotinib versus standard
chemotherapy as first-line treatment for European patients with
advanced EGFR mutation-positive non-small-cell lung cancer
(EURTAC): A multicentre, open-label, randomised phase 3 trial.
Lancet Oncolog. 13:239–246. 2012. View Article : Google Scholar
|
|
3
|
Shitara K, Kondo C, Takahari D, Ura T,
Muro K and Matsuo K: Reporting patient characteristics and
stratification factors in randomized trials of systemic
chemotherapy for advanced gastric cancer. Gastric Cancer.
15:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baek HU, Sang BK, Cho EH, Jin SH, Yu HJ,
Lee JI, Bang HY and Lim CS: Hepatic resection for hepatic
metastases from gastric adenocarcinoma. J Gastric Cancer. 13:86–92.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heinrich JN, Kwak SP, Howland DS, Chen J,
Sturner S, Sullivan K, Lipinski K, Cheng KY, She Y, Lo F, et al:
Disruption of ShcA signaling halts cell
proliferation-Characterization of ShcC residues that influence
signaling pathways using yeast. Cell Signal. 18:795–806. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferro M, Savino MT, Ortensi B, Finetti F,
Genovese L, Masi G, Ulivieri C, Benati D, Pelicci G and Baldari CT:
The shc family protein adaptor, rai, negatively regulates T cell
antigen receptor signaling by inhibiting ZAP-70 recruitment and
activation. PLoS One. 6:e298992011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shih HJ, Chen HH, Chen YA, Wu MH, Liou GG,
Chang WW, Chen L, Wang LH and Hsu HL: Targeting MCT-1 oncogene
inhibits Shc pathway and xenograft tumorigenicity. Oncotarget.
3:1401–1415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Francia P, Cosentino F, Schiavoni M, Huang
Y, Perna E, Camici GG, Lüscher TF and Volpe M: p66Shc
protein, oxidative stress, and cardiovascular complications of
diabetes: The missing link. J Mol Med. 87:885–891. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asano E, Hasegawa H, Hyodo T, Ito S, Maeda
M, Chen D, Takahashi M, Hamaguchi M and Senga T: SHCBP1 is required
for midbody organization and cytokinesis completion. Cell Cycle.
13:2744–2751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tao HC, Wang HX, Dai M, Gu CY, Wang Q, Han
ZG and Cai B: Targeting SHCBP1 inhibits cell proliferation in human
hepatocellular carcinoma cells. Asian Pac J Cancer Prev.
14:5645–5650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asano E, Hasegawa H, Hyodo T, Ito S, Maeda
M, Takahashi M, Hamaguchi M and Senga T: The Aurora-B-mediated
phosphorylation of SHCBP1 regulates cytokinetic furrow ingression.
J Cell Sci. 126:3263–3270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng C, Zhao H, Chen W, Song Y, Wang X, Li
J, Qiao Y, Wu D, Ma S, Wang X, et al: Identification of SHCBP1 as a
novel downstream target gene of SS18-SSX1 and its functional
analysis in progression of synovial sarcoma. Oncotarget.
7:66822–66834. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van CE: The treatment of advanced gastric
cancer: New findings on the activity of the taxanes. Oncologist.
2:9–15. 2004.
|
|
15
|
Aoyama T, Maezawa Y and Sawazaki S:
Evaluation of clinic pathological characteristics and prognosis of
gastric cancer in elderly patients. Ann Cancer Res Ther. 26:31–32.
2018. View Article : Google Scholar
|
|
16
|
Deng X, Liu P, Zhao Y and Wang Q:
Expression profiling of CEACAM6 associated with the tumorigenesis
and progression in gastric adenocarcinoma. Genet Mol Res.
13:7686–7697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren G, Tian Q, An Y, Feng B, Lu Y, Liang
J, Li K, Shang Y, Nie Y, Wang X and Fan D: Coronin 3 promotes
gastric cancer metastasis via the up-regulation of MMP-9 and
cathepsin K. Mol Cancer. 11:672012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Obenauf AC and Massagué J: Surviving at a
distance: Organ specific metastasis. Trends Cancer. 1:76–91. 2015.
View Article : Google Scholar :
|
|
19
|
Romano F, Garancini M and Uggeri F,
Degrate L, Nespoli L, Gianotti L, Nespoli A and Uggeri F: Surgical
treatment of liver metastases of gastric cancer: State of the art.
World J Surg Oncol. 10:1572012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsuboi K, Kodera Y, Nakanishi H, Ito S,
Mochizuki Y, Nakayama G, Koike M, Fujiwara M, Yamamura Y and Nakao
A: Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does
not correlate with peritoneal metastasis. Oncol Rep. 20:1117–1123.
2008.PubMed/NCBI
|
|
21
|
Patra C, Boccaccini AR and Engel FB:
Vascularisation for cardiac tissue engineering: The extracellular
matrix. Thromb Haemost. 113:532–547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng C, Zhao H, Song Y, Chen W, Wang X,
Liu X, Zhang C, Zhao J, Li J, Cheng G, et al: SHCBP1 promotes
synovial sarcoma cell metastasis via targeting TGF-β1/Smad
signaling pathway and is associated with poor prognosis. J Exp
Clini Cancer Res. 36:1412017. View Article : Google Scholar
|
|
23
|
Feng W, Li HC, Xu K, Chen YF, Pan LY, Mei
Y, Cai H, Jiang YM, Chen T and Feng DX: SHCBP1 is over-expressed in
breast cancer and is important in the proliferation and apoptosis
of the human malignant breast cancer cell line. Gene. 587:91–97.
2016. View Article : Google Scholar : PubMed/NCBI
|
